70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFátima Cardoso, Martine Piccart, Laura J. van’t Veer et al.|New England Journal of Medicine|2016Cited by 2k
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifenSherene Loi, Christos Sotiriou, Maria Grazia Daidone et al.|BMC Genomics|2008Cited by 406
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Emiel J. Rutgers, Laura van ‘t Veer et al.|The Lancet Oncology|2021Cited by 355
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected PatientsStéphanie Bibert, Nicolas Guex, João Lourenço et al.|Frontiers in Immunology|2021Cited by 45
The MAQC-II Project: A comprehensive study of common practices for the development and validation of microarray-based predictive models.Leming Shi, Rafael A. Irizarry, Grant R. Campbell et al.|Unknown|2010Cited by 41